Current level of glycaemic control and its associated factors in patients with type 2 diabetes across Europe: Data from the PANORAMA study

Clinical Endocrinology

Volumn 80, Issue 1, 2014, Pages 47-56

  De Pablos Velasco, Pedro ^a   Parhofer, Klaus G ^b   Bradley, Clare ^c   Eschwège, Eveline ^d   Gönder Frederick, Linda ^e   Maheux, Pierre ^f   Wood, Ian ^g   Simon, Dominique ^h  

^a UNIVERSITY OF LAS PALMAS DE GRAN CANARIA   (Spain)

^b LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^c UNIVERSITY OF LONDON   (United Kingdom)

^d CENTRE FOR RESEARCH IN EPIDEMIOLOGY AND POPULATION HEALTH   (France)

^e UNIVERSITY OF VIRGINIA HEALTH SYSTEM   (United States)

^f ASTRAZENECA   (United Kingdom)

^g BRISTOL MYERS SQUIBB   (United States)

^h PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCAGON LIKE PEPTIDE 1 RECEPTOR AGONIST; HEMOGLOBIN A1C; INSULIN; ORAL ANTIDIABETIC AGENT;

ADULT; AGE DISTRIBUTION; ARTICLE; DISEASE DURATION; EUROPE; FEMALE; GLYCEMIC CONTROL; HEMOGLOBIN DETERMINATION; HUMAN; HYPOGLYCEMIA; LIFESTYLE; MAJOR CLINICAL STUDY; MALE; MEDICAL DEVICE; NON INSULIN DEPENDENT DIABETES MELLITUS; PATIENT COMPLIANCE; POST HOC ANALYSIS; PRIORITY JOURNAL;

AGED; BLOOD GLUCOSE; DIABETES MELLITUS, TYPE 2; EUROPE; FEMALE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS;

EID: 84889597204     PISSN: 03000664     EISSN: 13652265     Source Type: Journal    
DOI: 10.1111/cen.12119     Document Type: Article

References (40)

1. Nathan, D., Buse, J., Davidson, M., et al,. (2009) Medical management of hyperglycaemia in type 2 diabetes mellitus: a consensus algorithm for the initiation and adjustment of therapy. Diabetologia 52, 17-30.
2. Jellinger, P.S., Davidson, J.A., Blonde, L., et al,. (2007) Road maps to achieve glycemic control in type 2 diabetes mellitus: ACE/AACE Diabetes Road Map Task Force. Endocrine Practice 13, 260-268.
3. Gæde, P., Vedel, P., Larsen, N., et al,. (2003) Multifactorial Intervention and Cardiovascular Disease in Patients with Type 2 Diabetes. New England Journal of Medicine 348, 383-393.
4. UK Prospective Diabetes Study (UKPDS) Group (1998) Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet 352, 837-853.
5. Shaya, F.T., Yan, X., Lin, P.J., et al,. (2010) US trends in glycemic control, treatment, and comorbidity burden in patients with diabetes. The Journal of Clinical Hypertension 12, 826-832.
6. de Pablos-Velasco, P.L., Martinez-Martin, F.J., Molero, R., et al,. (2005) Patterns of prescription of hypoglycaemic drugs in Gran Canaria (Canary islands, Spain) and estimation of the prevalence of diabetes mellitus. Diabetes & Metabolism 31, 457-462.
7. Filion, K.B., Joseph, L., Boivin, J.F., et al,. (2009) Trends in the prescription of anti-diabetic medications in the United Kingdom: a population-based analysis. Pharmacoepidemiology and Drug Safety 18, 973-976.
8. Marant, C., Romon, I., Fosse, S., et al,. (2008) French medical practice in type 2 diabetes: the need for better control of cardiovascular risk factors. Diabetes & Metabolism 34, 38-45.
9. Parhofer, K.G., Zeymer, U., Stark, R.G., et al,. (2010) In Germany diabetic patients with coronary artery disease are treated more intensively than diabetic patients with other manifestations of atherothrombosis-results from the REACH registry. Experimental and Clinical Endocrinology & Diabetes 118, 51-56.
10. Liebl, A., Mata, M., &, Eschwege, E., (2002) Evaluation of risk factors for development of complications in Type II diabetes in Europe. Diabetologia 45, S23-S28.
11. Valensi, P., Benroubi, M., Borzi, V., et al,. (2009) Initiating insulin therapy with, or switching existing insulin therapy to, biphasic insulin aspart 30/70 (NovoMix 30) in routine care: safety and effectiveness in patients with type 2 diabetes in the IMPROVE observational study. International Journal of Clinical Practice 63, 522-531.
12. UK Prospective Diabetes Study (UKPDS) Group (1998) Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group. Lancet 352, 854-865.
13. Pyorala, K., Lehto, S., De, B.D., et al,. (2004) Risk factor management in diabetic and non-diabetic patients with coronary heart disease. Findings from the EUROASPIRE I AND II surveys. Diabetologia 47, 1257-1265.
14. Kotseva, K., Wood, D., De, B.G., et al,. (2009) Cardiovascular prevention guidelines in daily practice: a comparison of EUROASPIRE I, II, and III surveys in eight European countries. Lancet 373, 929-940.
15. Bradley, C., de Pablos-Velasco, P., Parhofer, K.G., et al,. (2011) PANORAMA: A European study to evaluate quality of life and treatment satisfaction in patients with type 2 (diabetes), mellitus-Study. Primary Care Diabetes 5, 231-239.
16. Bode, B.W., Irvin, B.R., Pierce, J.A., et al,. (2007) Advances in hemoglobin A1c point of care technology. Journal of Diabetes Science and Technology 1, 405-411.
17. Lemke, C., &, Matthaei, S., (2009) The point-of-care (POC) A1CNow+ device: precision and accuracy of an improved version. Diabetes 58 (suppl 1), A111.
18. Chang, A., Frank, J., Knaebel, J., et al,. (2010) Evaluation of an over-the-counter glycated hemoglobin (A1C) test kit. Journal of Diabetes Science and Technology 4, 1495-1503.
19. Hoerger, T.J., Segel, J.E., Gregg, E.W., et al,. (2008) Is glycemic control improving in U.S. adults? Diabetes Care 31, 81-86.
20. Serrano-Gil, M., &, Jacob, S., (2010) Engaging and empowering patients to manage their type 2 diabetes, Part I: a knowledge, attitude, and practice gap? Advances in Therapy 27, 321-333.
21. Benoit, S.R., Fleming, R., Philis-Tsimikas, A., et al,. (2005) Predictors of glycemic control among patients with Type 2 diabetes: a longitudinal study. BMC Public Health 5, 36.
22. Willey, C.J., Andrade, S.E., Cohen, J., et al,. (2006) Polypharmacy with oral antidiabetic agents: an indicator of poor glycemic control. The American Journal of Managed Care 12, 435-440.
23. Donnelly, L.A., Morris, A.D., &, Evans, J.M., (2007) Adherence to insulin and its association with glycaemic control in patients with type 2 diabetes. Quarterly Journal of Medicine 100, 345-350.
24. Chan, J.C., Gagliardino, J.J., Baik, S.H., et al,. (2009) Multifaceted determinants for achieving glycemic control: the International Diabetes Management Practice Study (IDMPS). Diabetes Care 32, 227-233.
25. Blumenthal, K.J., Larkin, M.E., Winning, G., et al,. (2010) Changes in glycemic control from 1996 to 2006 among adults with type 2 diabetes: a longitudinal cohort study. BMC Health Services Research 10, 158.
26. Pani, L.N., Nathan, D.M., &, Grant, R.W., (2008) Clinical predictors of disease progression and medication initiation in untreated patients with type 2 diabetes and A1C less than 7%. Diabetes Care 31, 386-390.
27. Rubin, R.R., (2005) Adherence to pharmacologic therapy in patients with type 2 diabetes mellitus. American Journal of Medicine 118 (Suppl 5A), 27S-34S.
28. Boccuzzi, S.J., Wogen, J., Fox, J., et al,. (2001) Utilization of oral hypoglycemic agents in a drug-insured U.S. population. Diabetes Care 24, 1411-1415.
29. Ziemer, D.C., Miller, C.D., Rhee, M.K., et al,. (2005) Clinical inertia contributes to poor diabetes control in a primary care setting. The Diabetes Educator 31, 564-571.
30. Peyrot, M., Rubin, R.R., Lauritzen, T., et al,. (2005) Resistance to insulin therapy among patients and providers: results of the cross-national Diabetes Attitudes, Wishes, and Needs (DAWN) study. Diabetes Care 28, 2673-2679.
31. Duckworth, W., Abraira, C., Moritz, T., et al,. (2009) Glucose control and vascular complications in veterans with type 2 diabetes. The New England Journal of Medicine 360, 129-139.
32. Patel, A., MacMahon, S., Chalmers, J., et al,. (2008) Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes. The New England Journal of Medicine 358, 2560-2572.
33. Gerstein, H.C., Miller, M.E., Byington, R.P., et al,. (2008) Effects of intensive glucose lowering in type 2 diabetes. The New England Journal of Medicine 358, 2545-2559.
34. Ismail-Beigi, F., (2012) Clinical practice. Glycemic management of type 2 diabetes mellitus. The New England Journal of Medicine 366, 1319-1327.
35. Nguyen, N.T., Nguyen, X.M., Lane, J., et al,. (2011) Relationship between obesity and diabetes in a US adult population: findings from the National Health and Nutrition Examination Survey, 1999-2006. Obesity Surgery 21, 351-355.
36. Kogan, A.J., (2009) Overcoming obstacles to effective care of type 2 diabetes. The American Journal of Managed Care 15, S255-S262.
37. Abdul-Ghani, M.A., Tripathy, D., &, DeFronzo, R.A., (2006) Contributions of beta-cell dysfunction and insulin resistance to the pathogenesis of impaired glucose tolerance and impaired fasting glucose. Diabetes Care 29, 1130-1139.
38. Loveman, E., Frampton, G.K., &, Clegg, A.J., (2008) The clinical effectiveness of diabetes education models for Type 2 diabetes: a systematic review. Health Technology Assessment 12, 1-116.
39. Jacob, S., &, Serrano-Gil, M., (2010) Engaging and empowering patients to manage their type 2 diabetes, Part II: Initiatives for success. Advances in Therapy 27, 665-680.
40. Young, D., Furler, J., Vale, M., et al,. (2007) Patient Engagement and Coaching for Health: The PEACH study-a cluster randomised controlled trial using the telephone to coach people with type 2 diabetes to engage with their GPs to improve diabetes care: a study protocol. BMC Family Practice 8, 20.